ProNephro AKI (NGAL) is now FDA-Cleared     READ MORE

Search

Financial Calendar

Key Dates for 2026

March 12, 2026Deadline for shareholder proposals – Annual General Meeting
March 26, 2026Annual Report 2025
Publication is expected before 9 am
April 24, 2026Annual General Meeting
May 21, 2026Interim Report – for the three-month period ended March 31, 2026
Publication is expected before 9 am
August 20, 2026Interim Report – for the six-month period ended June 30, 2026
Publication is expected before 9 am
November 19, 2026Interim Report – for the nine-month period ended September 30, 2026
Publication is expected before 9 am